From IMI to IHI - We have a new name. Find out why, and what else has changed…

Why we're changing

Project factsheets

The Innovative Health Initiative builds on the successes of the Innovative Medicines Initiative (IMI), which launched over 180 projects. Many IMI projects are still ongoing and are monitored by the IHI Programme Office. This section features the factsheets of all IMI projects. Once IHI projects are up and running, we will also promote them here.

IMI1/IMI2/IHI

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

Clear all filters

Displaying 5 projects/programmes

ADVANCE

Accelerated development of vaccine benefit-risk collaboration in Europe

Closed IMI1 Infectious diseases Vaccines Methods for benefit/risk assessment

DRIVE-AB

Driving re-investment in R&D and responsible antibiotic use

Closed IMI1 Antimicrobial resistance Infectious diseases ND4BB Methods for benefit/risk assessment

PREFER

Patient Preferences in benefit risk assessments during the drug life cycle

Closed IMI2 Clinical trial design Patient involvement in R&D Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment

PREFER

PROTECT

Pharmacoepidemiological research on outcomes of therapeutics by a European consortium

Closed IMI1 Tools for predicting/monitoring efficacy Methods for benefit/risk assessment

WEB-RADR 2

WEB-RADR 2

Closed IMI2 Tools for predicting/monitoring safety Big data and knowledge management Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment